Quality of life of Patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C : Results from the EORTC phase-III trial 30893 von FOSS, S. D, CURRAN, D, AARONSON, N. K, KEUPPENS, F, KLIMENT, J, ROBINSON, M. R. G, DEREIJKE, T. M, HETHERINGTON, J, KIL, P. J. M, REA, L. A

Volltext

Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer von de Boer, E C, Somogyi, L, de Ruiter, G J, W, de Reijke, Th M, Kurth, K -h, Schamhart, D H, J

Volltext

Intermittent androgen deprivation in advanced prostate cancer von de Reijke, T M

Volltext

Kinetics of prostate-specific antigen after manipulation of the prostate von Bossens, M.M.F., Straalen, J.P.Van, De Reijke, Th.M., Kurth, K.H., Sanders, G.T.B.

Volltext

Incidental carcinoma of the prostate von Van Andel, George, Vleeming, Ruud, Kurth, Karlheinz, De Reijke, Theo M.

Volltext

Tumor growth delay by laser-generated shock waves von de Reijke, Theo M., Schamhart, Denis H., Kurth, Karl-Heinz, Löwik, Clemens W., Donkers, Laurens H., Sterenborg, Henricus J.

Volltext